Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.64 DKK | +0.30% |
|
+3.73% | +24.05% |
Jun. 26 | Otsuka and Lundbeck's PTSD Treatment Moves Forward as FDA Accepts New Drug Application | MT |
Jun. 25 | US FDA Accepts Lundbeck, Otsuka's New Drug Application for PTSD Combo Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.05% | 5.67B | |
+24.25% | 76.12B | |
-6.29% | 23.28B | |
+13.21% | 8.54B | |
-3.37% | 7.81B | |
-34.20% | 6.43B | |
+4.26% | 4.17B | |
-5.77% | 3.86B | |
+13.15% | 3.33B | |
-12.77% | 3.17B |
- Stock Market
- Equities
- HLUN B Stock
- News H. Lundbeck A/S
- Transcript : H. Lundbeck A/S Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 10